These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15249330)

  • 1. Successful treatment with fenofibrate, a peroxisome proliferator activated receptor alpha ligand, for a patient with rheumatoid arthritis.
    Okamoto H; Kamatani N
    Ann Rheum Dis; 2004 Aug; 63(8):1002-3. PubMed ID: 15249330
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.
    Theocharis S; Margeli A; Vielh P; Kouraklis G
    Cancer Treat Rev; 2004 Oct; 30(6):545-54. PubMed ID: 15325034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.
    Hiuge A; Tenenbaum A; Maeda N; Benderly M; Kumada M; Fisman EZ; Tanne D; Matas Z; Hibuse T; Fujita K; Nishizawa H; Adler Y; Motro M; Kihara S; Shimomura I; Behar S; Funahashi T
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):635-41. PubMed ID: 17194889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menarini Academy Cardiovascular Research Awards in Basic Science 2001: ligands of the orphan receptor peroxisome-proliferator activator-gamma reduce myocardial infarct size.
    Thiemermann C; Wayman NS
    Med Sci Monit; 2001; 7(4):787-9. PubMed ID: 11433213
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of melanoma metastases by fenofibrate.
    Grabacka M; Placha W; Plonka PM; Pajak S; Urbanska K; Laidler P; Slominski A
    Arch Dermatol Res; 2004 Jul; 296(2):54-8. PubMed ID: 15278363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with fenofibrate of autoimmune hepatitis in a patient with rheumatoid arthritis.
    Okamoto H; Kamatani N
    Scand J Rheumatol; 2007; 36(3):235-6. PubMed ID: 17657681
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful etanercept use in an HIV-positive patient with rheumatoid arthritis.
    Kaur PP; Chan VC; Berney SN
    J Clin Rheumatol; 2007 Apr; 13(2):79-80. PubMed ID: 17414534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
    Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand specificity of nuclear hormone receptors: sifting through promiscuity.
    Noy N
    Biochemistry; 2007 Nov; 46(47):13461-7. PubMed ID: 17983246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear hormone receptors and intestinal inflammation.
    Wu GD
    Gastroenterology; 2007 Oct; 133(4):1068. PubMed ID: 17919480
    [No Abstract]   [Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
    Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: preparation of FXR and PPAR ligands.
    Kainuma M; Kasuga J; Hosoda S; Wakabayashi K; Tanatani A; Nagasawa K; Miyachi H; Makishima M; Hashimoto Y
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3213-8. PubMed ID: 16617018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.
    Delayre-Orthez C; Becker J; Auwerx J; Frossard N; Pons F
    Eur J Pharmacol; 2008 Feb; 581(1-2):177-84. PubMed ID: 18096152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of peroxisome proliferator-activated receptor alpha ligand fenofibrate on K(v) channels in the insulin-secreting cell line HIT-T15.
    Shimomura K; Ikeda M; Ariyama Y; Proks P; Shimomura Y; Mori M; Matsumoto S
    Gen Physiol Biophys; 2006 Dec; 25(4):455-60. PubMed ID: 17356236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis in pregnancy: successful outcome with anti-TNF agent (Etanercept).
    Sinha A; Patient C
    J Obstet Gynaecol; 2006 Oct; 26(7):689-91. PubMed ID: 17071443
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis.
    Hammoudeh M
    Rheumatology (Oxford); 2006 Mar; 45(3):357-9. PubMed ID: 16368727
    [No Abstract]   [Full Text] [Related]  

  • 18. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
    Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A
    Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
    [No Abstract]   [Full Text] [Related]  

  • 20. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.